Help us make responsible and inclusive cannabis legislation possible for all Texans.

August 20, 2021

FREE Webinar – Cannabis Litigation: What You Need to Know

Register HERE! Cannabis disputes are unique. They are typically more complex than disputes involving other industries and they are often “bet the business” affairs. Over the years, we have developed and prosecuted successful litigation strategies for many of our clients across the country and around the world. Harris Bricken litigators regularly advise cannabis and hemp […]

FREE Webinar – Cannabis Litigation: What You Need to Know Read More »

The FDA Continues to Show It Is Not Interested in Regulating Hemp-Derived Products

Last week, the Food and Drug Administration (the “FDA”) maintained its strict and narrow position on the legality of cannabidiol (“CBD”) by rejecting two new dietary ingredient (“NDI”) notifications submitted by Charlotte’s Web and Irwin Naturals. Both companies sought agency clearance to market their full-spectrum hemp extract as “dietary supplements.” In its letters to these

The FDA Continues to Show It Is Not Interested in Regulating Hemp-Derived Products Read More »

Donate to the cause

Help us make responsible and inclusive cannabis legislation possible for all Texans.